-
Signature
-
/s/ David Owens Name: David Owens, M.D.
-
Issuer symbol
-
NXL
-
Transactions as of
-
19 Dec 2025
-
Transactions value $
-
$0
-
Form type
-
4
-
Filing time
-
23 Dec 2025, 09:41:08 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Owens David |
Chief Medical Officer, Director |
4545 HARRIS TRAIL NW, ATLANTA |
/s/ David Owens Name: David Owens, M.D. |
23 Dec 2025 |
0001916664 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
NXL |
Stock Option (right to buy)* |
Award |
$0 |
+1M |
+67.35% |
$0.00 |
2.48M |
19 Dec 2025 |
Common Stock |
1M |
$0.83 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
*Granted under the 2023 Equity Incentive Plan, subject to Shareholder Approval to increase the Plan limit under NASDAQ Rules.